Document Classification

Section Type: RESULTS

Text: In the last 2 studies, 2 cohorts of white patients (cohort 1, 15 patients with ET ; 10 women, 5 men ; mean [SD] age, 49. 0 [10. 7] years [range, 31-66 years] ; weight, 73. 2 [12. 6] kg ; cohort 2, 19 patients with thrombocythemia associated with CMPD ; 12 women, 7 men ; age, 62. 6 [12. 4] years [range, 38-80 years] ; weight, 66. 1 [13. 3] kg) who had received treatment for > or = 3 months with the reference formulation were switched to the same dose of the test formulation and maintained on this dose for 4 weeks.